Date of Award
2026
Degree Name
Pharmaceutical Sciences
College
School of Pharmacy
Type of Degree
M.S.
Document Type
Thesis
First Advisor
Dr. Gary O. Rankin
Second Advisor
Dr. Monica Valentovic
Third Advisor
Dr. Michael Hambuchen
Fourth Advisor
Dr. Hasan Koc
Abstract
Brominated and chlorinated benzenes are common industrial chemicals linked to kidney injury. This study evaluated the nephrotoxicity of several mono- and dihalogenated derivatives using isolated kidney cells from male Fischer 344 rats. LDH release and trypan blue exclusion were measured after 30- and 60-minute exposures to 0.25–1.0 mM to test compounds. Toxicity increased with increased concentration and longer times. Mixed-halogen bromobenzenes, particularly 1-bromo-4-chlorobenzene, showed one of the highest toxicity levels, while 1,4dichlorobenzene was the most toxic chlorobenzene. Antioxidants (glutathione, ascorbate, and αtocopherol) markedly reduced injury, indicating oxidative mechanisms play a role in toxicity. cytochromes P450 (CYP) inhibitors (piperonyl butoxide and metyrapone) decreased toxicity, demonstrating that metabolic activation contributed to cell damage. Deferoxamine reduced injury by limiting iron-driven radical formation. These findings show that halogen substitution patterns strongly influence cytotoxicity and that oxidative stress and CYP-dependent metabolism drive the nephrotoxic response to dihalobenzene exposure.
Subject(s)
Pharmaceutical chemistry.
Pharmacology.
Kidneys.
Hazardous substances.
Toxicity testing -- In vitro.
Benzene.
Antioxidants.
Deferoxamine.
Oxidative stress.
Recommended Citation
Sherif, Jana Ahmed, "In vitro dihalobenzene nephrotoxicity in isolated kidney cells" (2026). Theses, Dissertations and Capstones. 2043.
https://mds.marshall.edu/etd/2043
